An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects
Clinical trial NCT02793154 · TERMINATED
Trial details
- NCT number
- NCT02793154
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-26
- Primary completion
- 2017-03-16
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.